{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T18:31:25Z","timestamp":1773685885920,"version":"3.50.1"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s11102-026-01638-0","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T13:56:58Z","timestamp":1770472618000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sex-related differences in healthcare utilization and costs among patients with pituitary adenomas"],"prefix":"10.1007","volume":"29","author":[{"given":"Hayri","family":"Bostan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iris C. M.","family":"Pelsma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nienke R.","family":"Biermasz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,7]]},"reference":[{"key":"1638_CR1","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s42000-019-00168-8","volume":"19","author":"M Araujo-Castro","year":"2020","unstructured":"Araujo-Castro M, Berrocal VR, Pascual-Corrales E (2020) Pituitary tumors: epidemiology and clinical presentation spectrum. Hormones 19:145\u2013155. https:\/\/doi.org\/10.1007\/s42000-019-00168-8","journal-title":"Hormones"},{"key":"1638_CR2","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/s41574-025-01134-8","volume":"21","author":"M Fleseriu","year":"2025","unstructured":"Fleseriu M, Gurnell M, McCormack A et al (2025) Pituitary incidentaloma: a Pituitary Society international consensus guideline statement. Nat Rev Endocrinol 21:638\u2013655. https:\/\/doi.org\/10.1038\/s41574-025-01134-8","journal-title":"Nat Rev Endocrinol"},{"key":"1638_CR3","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/cncr.20412","volume":"101","author":"S Ezzat","year":"2004","unstructured":"Ezzat S, Asa SL, Couldwell WT et al (2004) The prevalence of pituitary adenomas: a systematic review. Cancer 101:613\u2013619. https:\/\/doi.org\/10.1002\/cncr.20412","journal-title":"Cancer"},{"key":"1638_CR4","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.beem.2009.05.001","volume":"23","author":"ME Molitch","year":"2009","unstructured":"Molitch ME (2009) Pituitary incidentalomas. Best Pract Res Clin Endocrinol Metab 23:667\u2013675. https:\/\/doi.org\/10.1016\/j.beem.2009.05.001","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"1638_CR5","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ecl.2020.04.002","volume":"49","author":"AF Daly","year":"2020","unstructured":"Daly AF, Beckers A (2020) The epidemiology of pituitary adenomas. Endocrinol Metab Clin North Am 49:347\u2013355. https:\/\/doi.org\/10.1016\/j.ecl.2020.04.002","journal-title":"Endocrinol Metab Clin North Am"},{"key":"1638_CR6","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/s41574-023-00868-7","volume":"19","author":"M Fleseriu","year":"2023","unstructured":"Fleseriu M, Varlamov EV, Hinojosa-Amaya JM, Langlois F, Melmed S (2023) An individualized approach to the management of Cushing disease. Nat Rev Endocrinol 19:581\u2013599. https:\/\/doi.org\/10.1038\/s41574-023-00868-7","journal-title":"Nat Rev Endocrinol"},{"key":"1638_CR7","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s11102-015-0695-9","volume":"19","author":"T Burton","year":"2016","unstructured":"Burton T, Le Nestour E, Neary M, Ludlam WH (2016) Algorithm development and the clinical and economic burden of Cushing\u2019s disease in a large US health plan database. Pituitary 19:167\u2013174. https:\/\/doi.org\/10.1007\/s11102-015-0695-9","journal-title":"Pituitary"},{"key":"1638_CR8","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1007\/s11102-015-0654-5","volume":"18","author":"MS Broder","year":"2015","unstructured":"Broder MS, Neary MP, Chang E, Ludlam WH (2015) Incremental healthcare resource utilization and costs in US patients with Cushing\u2019s disease compared with diabetes mellitus and population controls. Pituitary 18:796\u2013802. https:\/\/doi.org\/10.1007\/s11102-015-0654-5","journal-title":"Pituitary"},{"key":"1638_CR9","doi-asserted-by":"publisher","first-page":"681","DOI":"10.4158\/EP10368.OR","volume":"17","author":"B Swearingen","year":"2011","unstructured":"Swearingen B, Wu N, Chen SY, Pulgar S, Biller BM (2011) Health care resource use and costs among patients with Cushing disease. Endocr Pract 17:681\u2013690. https:\/\/doi.org\/10.4158\/EP10368.OR","journal-title":"Endocr Pract"},{"key":"1638_CR10","doi-asserted-by":"publisher","first-page":"77","DOI":"10.4158\/EP14126.OR","volume":"21","author":"MS Broder","year":"2015","unstructured":"Broder MS, Neary MP, Chang E, Cherepanov D, Ludlam WH (2015) Burden of illness, annual healthcare utilization, and costs associated with commercially insured patients with Cushing disease in the united States. Endocr Pract 21:77\u201386. https:\/\/doi.org\/10.4158\/EP14126.OR","journal-title":"Endocr Pract"},{"key":"1638_CR11","doi-asserted-by":"publisher","first-page":"86","DOI":"10.5603\/ep.103200","volume":"76","author":"M Elbaum","year":"2025","unstructured":"Elbaum M, Ka\u0142u\u017cny M, Jawiarczyk-Przyby\u0142owska A, Wojtczak B, Zembska A, Bolanowski M (2025) The costs of acromegaly management in Poland - analysis from one centre. Endokrynol Pol 76:86\u201393. https:\/\/doi.org\/10.5603\/ep.103200","journal-title":"Endokrynol Pol"},{"key":"1638_CR12","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3389\/fpubh.2020.00147","volume":"8","author":"M Kamusheva","year":"2020","unstructured":"Kamusheva M, Vandeva S, Mitov K et al (2020) New epidemiological, clinical and economic data for patients with acromegaly in Bulgaria. Front Public Health 8:147. https:\/\/doi.org\/10.3389\/fpubh.2020.00147","journal-title":"Front Public Health"},{"key":"1638_CR13","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1530\/EJE-16-0623","volume":"176","author":"E Les\u00e9n","year":"2017","unstructured":"Les\u00e9n E, Granfeldt D, Houchard A et al (2017) Comorbidities, treatment patterns and cost-of-illness of acromegaly in Sweden: a register-linkage population-based study. Eur J Endocrinol 176:203\u2013212. https:\/\/doi.org\/10.1530\/EJE-16-0623","journal-title":"Eur J Endocrinol"},{"key":"1638_CR14","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2165\/11599680-000000000-00000","volume":"32","author":"M Roset","year":"2012","unstructured":"Roset M, Merino-Montero S, Luque-Ram\u00edrez M, Spanish group of the OASIS study et al (2012) Cost of clinical management of acromegaly in Spain. Clin Drug Investig 32:235\u2013245. https:\/\/doi.org\/10.2165\/11599680-000000000-00000","journal-title":"Clin Drug Investig"},{"key":"1638_CR15","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1007\/s11102-021-01193-w","volume":"25","author":"F Cocchiara","year":"2022","unstructured":"Cocchiara F, Campana C, Nista F et al (2022) Evaluation of acromegaly treatment direct costs with respect to biochemical control and follow-up length. Pituitary 25:246\u2013257. https:\/\/doi.org\/10.1007\/s11102-021-01193-w","journal-title":"Pituitary"},{"key":"1638_CR16","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s11102-013-0506-0","volume":"17","author":"MS Broder","year":"2014","unstructured":"Broder MS, Neary MP, Chang E, Cherepanov D, Katznelson L (2014) Treatments, complications, and healthcare utilization associated with acromegaly: a study in two large United States databases. Pituitary 17:333\u2013341. https:\/\/doi.org\/10.1007\/s11102-013-0506-0","journal-title":"Pituitary"},{"key":"1638_CR17","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1080\/13696998.2021.1898968","volume":"24","author":"A Ribeiro-Oliveira","year":"2021","unstructured":"Ribeiro-Oliveira A, Brook RA, Munoz KA et al (2021) Burden of acromegaly in the United States: increased health services utilization, location of care, and costs of care. J Med Econ 24:432\u2013439. https:\/\/doi.org\/10.1080\/13696998.2021.1898968","journal-title":"J Med Econ"},{"key":"1638_CR18","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.18553\/jmcp.2015.21.12.1106","volume":"21","author":"H Placzek","year":"2015","unstructured":"Placzek H, Xu Y, Mu Y, Begelman SM, Fisher M (2015) Clinical and economic burden of commercially insured patients with acromegaly in the United States: a retrospective analysis. J Manag Care Spec Pharm 21:1106\u20131112. https:\/\/doi.org\/10.18553\/jmcp.2015.21.12.1106","journal-title":"J Manag Care Spec Pharm"},{"key":"1638_CR19","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1136\/jim-2017-000570","volume":"66","author":"S Liu","year":"2018","unstructured":"Liu S, Adelman DT, Xu Y et al (2018) Patient-centered assessment on disease burden, quality of life, and treatment satisfaction associated with acromegaly. J Investig Med 66:653\u2013660. https:\/\/doi.org\/10.1136\/jim-2017-000570","journal-title":"J Investig Med"},{"key":"1638_CR20","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1111\/j.1464-5491.2009.02786.x","volume":"26","author":"K Bolin","year":"2009","unstructured":"Bolin K, Gip C, M\u00f6rk AC, Lindgren B (2009) Diabetes, healthcare cost and loss of productivity in Sweden 1987 and 2005\u2013a register-based approach. Diabet Med 26:928\u2013934. https:\/\/doi.org\/10.1111\/j.1464-5491.2009.02786.x","journal-title":"Diabet Med"},{"key":"1638_CR21","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1093\/ejendo\/lvad057","volume":"188","author":"DS Olsson","year":"2023","unstructured":"Olsson DS, Svensson M, Labori F, De Geer A, Johannsson G (2023) Healthcare cost and survival in patients with non-functioning pituitary adenoma. Eur J Endocrinol 188:477\u2013484. https:\/\/doi.org\/10.1093\/ejendo\/lvad057","journal-title":"Eur J Endocrinol"},{"key":"1638_CR22","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s12020-019-01847-7","volume":"64","author":"DJ Lobatto","year":"2019","unstructured":"Lobatto DJ, van den Hout WB, Zamanipoor Najafabadi AH et al (2019) Healthcare utilization and costs among patients with non-functioning pituitary adenomas. Endocrine 64:330\u2013340. https:\/\/doi.org\/10.1007\/s12020-019-01847-7","journal-title":"Endocrine"},{"key":"1638_CR23","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s11102-020-01089-1","volume":"24","author":"M van der Meulen","year":"2021","unstructured":"van der Meulen M, Zamanipoor Najafabadi AH, Lobatto DJ et al (2021) Healthcare utilization and costs among prolactinoma patients: a cross-sectional study and analysis of determinants. Pituitary 24:79\u201395. https:\/\/doi.org\/10.1007\/s11102-020-01089-1","journal-title":"Pituitary"},{"key":"1638_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.33393\/grhta.2024.2601","volume":"11","author":"M Basile","year":"2024","unstructured":"Basile M, Valentini I, Attanasio R et al (2024) A Pharmacoeconomic analysis from Italian guidelines for the management of prolactinomas. Glob Reg Health Technol Assess 11:1\u201316. https:\/\/doi.org\/10.33393\/grhta.2024.2601","journal-title":"Glob Reg Health Technol Assess"},{"key":"1638_CR25","doi-asserted-by":"publisher","first-page":"123792","DOI":"10.1016\/j.wneu.2025.123792","volume":"196","author":"A Sarikonda","year":"2025","unstructured":"Sarikonda A, Quraishi D, Glener S et al (2025) Drivers of intraoperative costs for transsphenoidal endoscopic surgery for sellar lesions: a time-driven activity-based cost analysis. World Neurosurg 196:123792. https:\/\/doi.org\/10.1016\/j.wneu.2025.123792","journal-title":"World Neurosurg"},{"key":"1638_CR26","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1093\/neuros\/nyy441","volume":"85","author":"AO Asemota","year":"2019","unstructured":"Asemota AO, Ishii M, Brem H, Gallia GL (2019) Costs and their predictors in transsphenoidal pituitary surgery. Neurosurgery 85:695\u2013707. https:\/\/doi.org\/10.1093\/neuros\/nyy441","journal-title":"Neurosurgery"},{"key":"1638_CR27","doi-asserted-by":"publisher","first-page":"504","DOI":"10.3171\/2013.1.JNS121375","volume":"119","author":"AS Little","year":"2013","unstructured":"Little AS, Chapple K (2013) Predictors of resource utilization in transsphenoidal surgery for Cushing disease. J Neurosurg 119:504\u2013511. https:\/\/doi.org\/10.3171\/2013.1.JNS121375","journal-title":"J Neurosurg"},{"key":"1638_CR28","doi-asserted-by":"publisher","first-page":"905019","DOI":"10.3389\/fendo.2022.905019","volume":"13","author":"AJ Dekkers","year":"2022","unstructured":"Dekkers AJ, de Vries F, Najafabadi AHZ et al (2022) Costs and its determinants in pituitary tumour surgery. Front Endocrinol 13:905019. https:\/\/doi.org\/10.3389\/fendo.2022.905019","journal-title":"Front Endocrinol"},{"key":"1638_CR29","doi-asserted-by":"publisher","first-page":"R67","DOI":"10.1530\/EJE-19-1023","volume":"182","author":"NF Lenders","year":"2020","unstructured":"Lenders NF, McCormack AI, Ho KKY (2020) Management of endocrine disease: does gender matter in the management of acromegaly? Eur J Endocrinol 182:R67\u2013R82. https:\/\/doi.org\/10.1530\/EJE-19-1023","journal-title":"Eur J Endocrinol"},{"key":"1638_CR30","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1007\/s11102-015-0702-1","volume":"19","author":"I Kreitschmann-Andermahr","year":"2016","unstructured":"Kreitschmann-Andermahr I, Siegel S, Kleist B et al (2016) Diagnosis and management of acromegaly: the patient\u2019s perspective. Pituitary 19:268\u2013276. https:\/\/doi.org\/10.1007\/s11102-015-0702-1","journal-title":"Pituitary"},{"key":"1638_CR31","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/cen.14392","volume":"94","author":"J Dal","year":"2021","unstructured":"Dal J, Skov BG, Andersen M et al (2021) Sex differences in acromegaly at diagnosis: A nationwide cohort study and meta-analysis of the literature. Clin Endocrinol 94:625\u2013635. https:\/\/doi.org\/10.1111\/cen.14392","journal-title":"Clin Endocrinol"},{"key":"1638_CR32","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1530\/ERC-17-0253","volume":"24","author":"P Petrossians","year":"2017","unstructured":"Petrossians P, Daly AF, Natchev E et al (2017) Acromegaly at diagnosis in 3173 patients from the Li\u00e8ge Acromegaly Survey (LAS) database. Endocr Relat Cancer 24:505\u2013518. https:\/\/doi.org\/10.1530\/ERC-17-0253","journal-title":"Endocr Relat Cancer"},{"key":"1638_CR33","doi-asserted-by":"publisher","first-page":"610519","DOI":"10.3389\/fendo.2020.610519","volume":"11","author":"X Guo","year":"2020","unstructured":"Guo X, Wang K, Yu S et al (2020) Patient characteristics, diagnostic delays, treatment patterns, treatment outcomes, comorbidities, and treatment costs of acromegaly in China: a nationwide study. Front Endocrinol 11:610519. https:\/\/doi.org\/10.3389\/fendo.2020.610519","journal-title":"Front Endocrinol"},{"key":"1638_CR34","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/cen.12112","volume":"79","author":"S Vallette","year":"2013","unstructured":"Vallette S, Ezzat S, Chik C et al (2013) Emerging trends in the diagnosis and treatment of acromegaly in Canada. Clin Endocrinol 79:79\u201385. https:\/\/doi.org\/10.1111\/cen.12112","journal-title":"Clin Endocrinol"},{"key":"1638_CR35","doi-asserted-by":"publisher","first-page":"bvad104","DOI":"10.1210\/jendso\/bvad104","volume":"7","author":"M Fleseriu","year":"2023","unstructured":"Fleseriu M, Barkan A, Brue T et al (2023) Treatment patterns, adherence, persistence, and health care resource utilization in acromegaly: a real-world analysis. J Endocr Soc 7:bvad104. https:\/\/doi.org\/10.1210\/jendso\/bvad104","journal-title":"J Endocr Soc"},{"key":"1638_CR36","doi-asserted-by":"publisher","first-page":"107455","DOI":"10.1016\/j.clineuro.2022.107455","volume":"222","author":"BM Lehrich","year":"2022","unstructured":"Lehrich BM, Birkenbeuel JL, Roman K et al (2022) Treatment selection towards active surveillance over definitive treatment for pituitary adenomas is influenced by sociodemographic factors. Clin Neurol Neurosurg 222:107455. https:\/\/doi.org\/10.1016\/j.clineuro.2022.107455","journal-title":"Clin Neurol Neurosurg"},{"key":"1638_CR37","doi-asserted-by":"publisher","first-page":"E15","DOI":"10.3171\/2023.8.FOCUS23467","volume":"55","author":"M Sabahi","year":"2023","unstructured":"Sabahi M, Maroufi SF, Wierzbicka A, Maniakhina L, Adada B, Borghei-Razavi H (2023) Healthcare disparities in pituitary surgery: a systematic review. Neurosurg Focus 55:E15. https:\/\/doi.org\/10.3171\/2023.8.FOCUS23467","journal-title":"Neurosurg Focus"},{"key":"1638_CR38","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1227\/neu.0000000000003471","volume":"97","author":"A Tang","year":"2025","unstructured":"Tang A, Abdallah HM, Gardner PA et al (2025) Factors associated with a higher 30-day hospitalization period for pituitary adenoma patients: introducing a novel outcome metric. Neurosurgery 97:1141\u20131152. https:\/\/doi.org\/10.1227\/neu.0000000000003471","journal-title":"Neurosurgery"},{"key":"1638_CR39","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1227\/neu.0000000000002890","volume":"95","author":"A Devarajan","year":"2024","unstructured":"Devarajan A, Vasan V, Dullea JT et al (2024) Clinical and operative risk factors associated with prolonged length of stay after endoscopic pituitary adenoma resection. Neurosurgery 95:392\u2013399. https:\/\/doi.org\/10.1227\/neu.0000000000002890","journal-title":"Neurosurgery"},{"key":"1638_CR40","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.wneu.2017.05.148","volume":"105","author":"M Karsy","year":"2017","unstructured":"Karsy M, Brock AA, Guan J, Bisson EF, Couldwell WT (2017) Assessment of cost drivers in transsphenoidal approaches for resection of pituitary tumors using the value-driven outcome database. World Neurosurg 105:818\u2013823. https:\/\/doi.org\/10.1016\/j.wneu.2017.05.148","journal-title":"World Neurosurg"},{"key":"1638_CR41","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s11102-016-0738-x","volume":"19","author":"CC Lee","year":"2016","unstructured":"Lee CC, Kimmell KT, Lalonde A et al (2016) Geographic variation in cost of care for pituitary tumor surgery. Pituitary 19:515\u2013521. https:\/\/doi.org\/10.1007\/s11102-016-0738-x","journal-title":"Pituitary"},{"key":"1638_CR42","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1002\/lary.29041","volume":"131","author":"AK Parasher","year":"2021","unstructured":"Parasher AK, Lerner DK, Glicksman JT et al (2021) Drivers of in-hospital costs following endoscopic transphenoidal pituitary surgery. Laryngoscope 131:760\u2013764. https:\/\/doi.org\/10.1002\/lary.29041","journal-title":"Laryngoscope"},{"key":"1638_CR43","doi-asserted-by":"publisher","first-page":"E2","DOI":"10.3171\/2014.11.FOCUS14694","volume":"38","author":"D Wilson","year":"2015","unstructured":"Wilson D, Jin DL, Wen T et al (2015) Demographic factors, outcomes, and patient access to transsphenoidal surgery for Cushing\u2019s disease: analysis of the Nationwide Inpatient Sample from 2002 to 2010. Neurosurg Focus 38:E2. https:\/\/doi.org\/10.3171\/2014.11.FOCUS14694","journal-title":"Neurosurg Focus"},{"key":"1638_CR44","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3171\/2014.2.JNS132095","volume":"121","author":"AS Little","year":"2014","unstructured":"Little AS, Chapple K, Jahnke H, White WL (2014) Comparative inpatient resource utilization for patients undergoing endoscopic or microscopic transsphenoidal surgery for pituitary lesions. J Neurosurg 121:84\u201390. https:\/\/doi.org\/10.3171\/2014.2.JNS132095","journal-title":"J Neurosurg"},{"key":"1638_CR45","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1093\/neuros\/nyx471","volume":"83","author":"J Guan","year":"2018","unstructured":"Guan J, Karsy M, Bisson EF, Couldwell WT (2018) Patient-level factors influencing hospital costs and short-term patient-reported outcomes after transsphenoidal resection of sellar tumors. Neurosurgery 83:726\u2013731. https:\/\/doi.org\/10.1093\/neuros\/nyx471","journal-title":"Neurosurgery"},{"key":"1638_CR46","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1002\/alr.22540","volume":"10","author":"S Vimawala","year":"2020","unstructured":"Vimawala S, Chitguppi C, Reilly E et al (2020) Predicting prolonged length of stay after endoscopic transsphenoidal surgery for pituitary adenoma. Int Forum Allergy Rhinol 10:785\u2013790. https:\/\/doi.org\/10.1002\/alr.22540","journal-title":"Int Forum Allergy Rhinol"},{"key":"1638_CR47","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1177\/19458924231193527","volume":"37","author":"V Vasan","year":"2023","unstructured":"Vasan V, Dullea JT, Devarajan A et al (2023) Predictors of prolonged length of stay after pituitary adenoma resection: a large cohort analysis using the National Inpatient Sample (2016\u20132019). Am J Rhinol Allergy 37:758\u2013765. https:\/\/doi.org\/10.1177\/19458924231193527","journal-title":"Am J Rhinol Allergy"},{"key":"1638_CR48","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1002\/alr.22148","volume":"8","author":"S McKee","year":"2018","unstructured":"McKee S, Yang A, Kidwai S, Govindaraj S, Shrivastava R, Iloreta A (2018) The socioeconomic determinants for transsphenoidal pituitary surgery: a review of New York State from 1995 to 2015. Int Forum Allergy Rhinol 8:1145\u20131156. https:\/\/doi.org\/10.1002\/alr.22148","journal-title":"Int Forum Allergy Rhinol"},{"key":"1638_CR49","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.3390\/jcm3041199","volume":"3","author":"SM Barber","year":"2014","unstructured":"Barber SM, Liebelt BD, Baskin DS (2014) Incidence, etiology and outcomes of hyponatremia after transsphenoidal surgery: experience with 344 consecutive patients at a single tertiary center. J Clin Med 3:1199\u20131219. https:\/\/doi.org\/10.3390\/jcm3041199","journal-title":"J Clin Med"},{"key":"1638_CR50","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1055\/s-0038-1676839","volume":"80","author":"SM Kidwai","year":"2019","unstructured":"Kidwai SM, Yang A, Gray ML et al (2019) Hospital charge variability across New York State: sociodemographic factors in pituitary surgery. J Neurol Surg B Skull Base 80:612\u2013619. https:\/\/doi.org\/10.1055\/s-0038-1676839","journal-title":"J Neurol Surg B Skull Base"},{"key":"1638_CR51","doi-asserted-by":"publisher","first-page":"148","DOI":"10.12290\/xhyxzz.2022-0068","volume":"14","author":"L Yang","year":"2023","unstructured":"Yang L, Wei J, Yin R et al (2023) Influencing factors of hospital costs for pituitary tumor under DRG payment. Med J Peking Union Med Coll Hosp 14:148\u2013152. https:\/\/doi.org\/10.12290\/xhyxzz.2022-0068","journal-title":"Med J Peking Union Med Coll Hosp"},{"key":"1638_CR52","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1055\/s-0039-1679896","volume":"81","author":"A Parikh","year":"2020","unstructured":"Parikh A, Adapa A, Sullivan SE, McKean EL (2020) Predictive factors, 30-day clinical outcomes, and costs associated with cerebrospinal fluid leak in pituitary adenoma resection. J Neurol Surg B Skull Base 81:43\u201355. https:\/\/doi.org\/10.1055\/s-0039-1679896","journal-title":"J Neurol Surg B Skull Base"},{"key":"1638_CR53","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s11102-019-01007-0","volume":"23","author":"KA Shaftel","year":"2020","unstructured":"Shaftel KA, Cole TS, Little AS (2020) National trends in hospital readmission following transsphenoidal surgery for pituitary lesions. Pituitary 23:79\u201391. https:\/\/doi.org\/10.1007\/s11102-019-01007-0","journal-title":"Pituitary"},{"key":"1638_CR54","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/alr.22241","volume":"9","author":"ZH Rizvi","year":"2019","unstructured":"Rizvi ZH, Ferrandino R, Luu Q, Suh JD, Wang MB (2019) Nationwide analysis of unplanned 30-day readmissions after transsphenoidal pituitary surgery. Int Forum Allergy Rhinol 9:322\u2013329. https:\/\/doi.org\/10.1002\/alr.22241","journal-title":"Int Forum Allergy Rhinol"},{"key":"1638_CR55","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s11102-017-0839-1","volume":"21","author":"DJ Lobatto","year":"2018","unstructured":"Lobatto DJ, de Vries F, Zamanipoor Najafabadi AH et al (2018) Preoperative risk factors for postoperative complications in endoscopic pituitary surgery: a systematic review. Pituitary 21:84\u201397. https:\/\/doi.org\/10.1007\/s11102-017-0839-1","journal-title":"Pituitary"},{"key":"1638_CR56","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1002\/lary.25120","volume":"125","author":"JA Villwock","year":"2015","unstructured":"Villwock JA, Villwock MR, Goyal P, Deshaies EM (2015) Current trends in surgical approach and outcomes following pituitary tumor resection. Laryngoscope 125:1307\u20131312. https:\/\/doi.org\/10.1002\/lary.25120","journal-title":"Laryngoscope"},{"key":"1638_CR57","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s11060-016-2342-3","volume":"132","author":"YJ Rao","year":"2017","unstructured":"Rao YJ, Hassanzadeh C, Fischer-Valuck B et al (2017) Patterns of care and treatment outcomes of patients with Craniopharyngioma in the national cancer database. J Neurooncol 132:109\u2013117. https:\/\/doi.org\/10.1007\/s11060-016-2342-3","journal-title":"J Neurooncol"},{"key":"1638_CR58","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1093\/neuros\/nyy269","volume":"84","author":"M Karsy","year":"2019","unstructured":"Karsy M, Bowers CA, Scoville J et al (2019) Evaluation of complications and costs during overlapping transsphenoidal surgery in the treatment of pituitary adenoma. Neurosurgery 84:1104\u20131111. https:\/\/doi.org\/10.1093\/neuros\/nyy269","journal-title":"Neurosurgery"},{"key":"1638_CR59","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1002\/lary.25161","volume":"125","author":"EF Spinazzi","year":"2015","unstructured":"Spinazzi EF, Pines MJ, Fang CH et al (2015) Impact and cost of care of venous thromboembolism following pituitary surgery. Laryngoscope 125:1563\u20131567. https:\/\/doi.org\/10.1002\/lary.25161","journal-title":"Laryngoscope"},{"key":"1638_CR60","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s40801-015-0039-0","volume":"2","author":"CC Chuang","year":"2015","unstructured":"Chuang CC, Bhurke S, Chen SY, Dinet J, Brulais S, Gabriel S (2015) Treatment patterns and economic burden in patients treated for acromegaly in the USA. Drugs Real World Outcomes 2:299\u2013309. https:\/\/doi.org\/10.1007\/s40801-015-0039-0","journal-title":"Drugs Real World Outcomes"},{"key":"1638_CR61","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/s41574-025-01148-2","volume":"21","author":"S Melmed","year":"2025","unstructured":"Melmed S, di Filippo L, Fleseriu M et al (2025) Consensus on acromegaly therapeutic outcomes: an update. Nat Rev Endocrinol 21:718\u2013737. https:\/\/doi.org\/10.1038\/s41574-025-01148-2","journal-title":"Nat Rev Endocrinol"},{"key":"1638_CR62","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","volume":"9","author":"M Fleseriu","year":"2021","unstructured":"Fleseriu M, Auchus R, Bancos I et al (2021) Consensus on diagnosis and management of Cushing\u2019s disease: a guideline update. Lancet Diabetes Endocrinol 9:847\u2013875. https:\/\/doi.org\/10.1016\/S2213-8587(21)00235-7","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1638_CR63","doi-asserted-by":"publisher","first-page":"e250069","DOI":"10.57264\/cer-2025-0069","volume":"14","author":"TP Quock","year":"2025","unstructured":"Quock TP, Chang E, Das AK et al (2025) Healthcare utilization and costs among patients with acromegaly in the United States. J Comp Eff Res 14:e250069. https:\/\/doi.org\/10.57264\/cer-2025-0069","journal-title":"J Comp Eff Res"},{"key":"1638_CR64","doi-asserted-by":"publisher","first-page":"e250070","DOI":"10.57264\/cer-2025-0070","volume":"14","author":"TP Quock","year":"2025","unstructured":"Quock TP, Chang E, Das AK et al (2025) Dosing patterns, healthcare resource utilization and costs among acromegaly patients who consistently use lanreotide and injectable octreotide. J Comp Eff Res 14:e250070. https:\/\/doi.org\/10.57264\/cer-2025-0070","journal-title":"J Comp Eff Res"},{"key":"1638_CR65","doi-asserted-by":"publisher","first-page":"e250080","DOI":"10.57264\/cer-2025-0080","volume":"14","author":"TP Quock","year":"2025","unstructured":"Quock TP, Chang E, Das AK et al (2025) Adherence, duration and healthcare costs in a real-world population of patients with acromegaly. J Comp Eff Res 14:e250080. https:\/\/doi.org\/10.57264\/cer-2025-0080","journal-title":"J Comp Eff Res"},{"key":"1638_CR66","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1530\/EJE-13-1022","volume":"171","author":"A Colao","year":"2014","unstructured":"Colao A, Vandeva S, Pivonello R et al (2014) Could different treatment approaches in acromegaly influence life expectancy? A comparative study between Bulgaria and Campania (Italy). Eur J Endocrinol 171:263\u2013273. https:\/\/doi.org\/10.1530\/EJE-13-1022","journal-title":"Eur J Endocrinol"},{"key":"1638_CR67","first-page":"e508","volume":"21","author":"SV Uum","year":"2014","unstructured":"Uum SV, Hurry M, Petrella R, Koch C, Dranitsaris G, Lacroix A (2014) Management of patients with cushing\u2019s disease: a Canadian cost of illness analysis. J Popul Ther Clin Pharmacol 21:e508\u2013e517","journal-title":"J Popul Ther Clin Pharmacol"},{"key":"1638_CR68","doi-asserted-by":"publisher","DOI":"10.1177\/2284240318755065","author":"FS Mennini","year":"2018","unstructured":"Mennini FS, Viti R, Bini C, Marcellusi A, Palazzo F (2018) Economic burden of disease of uncontrolled acromegalic patients: the acromegaly Italian collaborative study group. Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish. https:\/\/doi.org\/10.1177\/2284240318755065","journal-title":"Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish"},{"key":"1638_CR69","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1055\/s-0039-1696724","volume":"82","author":"R Fathy","year":"2021","unstructured":"Fathy R, Kuan E, Lee JYK et al (2021) Factors associated with and temporal trends in the use of radiation therapy for the treatment of pituitary adenoma in the National Cancer Database. J Neurol Surg B Skull Base 82:285\u2013294. https:\/\/doi.org\/10.1055\/s-0039-1696724","journal-title":"J Neurol Surg B Skull Base"},{"key":"1638_CR70","doi-asserted-by":"publisher","first-page":"e88460","DOI":"10.1371\/journal.pone.0088460","volume":"9","author":"CJ Yang","year":"2014","unstructured":"Yang CJ, Huang GS, Xiao FR, Lou MF (2014) Symptom distress and quality of life after stereotactic radiosurgery in patients with pituitary tumors: a questionnaire survey. PLoS One 9:e88460. https:\/\/doi.org\/10.1371\/journal.pone.0088460","journal-title":"PLoS One"},{"key":"1638_CR71","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1093\/ejendo\/lvad097","volume":"189","author":"S St\u00f6rmann","year":"2023","unstructured":"St\u00f6rmann S, Cuny T (2023) The socioeconomic burden of acromegaly. Eur J Endocrinol 189:R1\u2013R10. https:\/\/doi.org\/10.1093\/ejendo\/lvad097","journal-title":"Eur J Endocrinol"},{"key":"1638_CR72","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1080\/13102818.2019.1680317","volume":"33","author":"M Kamusheva","year":"2019","unstructured":"Kamusheva M, Rusenova Y, Vandeva S et al (2019) Economic and pharmaco-economic analysis of acromegaly treatment: a systematic review. Biotechnol Biotechnol Equip 33:1560\u20131571. https:\/\/doi.org\/10.1080\/13102818.2019.1680317","journal-title":"Biotechnol Biotechnol Equip"},{"key":"1638_CR73","doi-asserted-by":"publisher","first-page":"dgaa405","DOI":"10.1210\/clinem\/dgaa405","volume":"105","author":"J Dal","year":"2020","unstructured":"Dal J, Nielsen EH, Rasmussen UF et al (2020) Disease control and gender predict the socioeconomic effects of acromegaly: a nationwide cohort study. J Clin Endocrinol Metab 105:dgaa405. https:\/\/doi.org\/10.1210\/clinem\/dgaa405","journal-title":"J Clin Endocrinol Metab"},{"key":"1638_CR74","doi-asserted-by":"publisher","first-page":"e464","DOI":"10.1002\/edm2.464","volume":"7","author":"G Page-Wilson","year":"2024","unstructured":"Page-Wilson G, Oak B, Silber A et al (2024) Holistic burden of illness in patients with endogenous Cushing\u2019s syndrome: a systematic literature review. Endocrinology Diabetes Metab 7:e464. https:\/\/doi.org\/10.1002\/edm2.464","journal-title":"Endocrinology Diabetes Metab"},{"key":"1638_CR75","doi-asserted-by":"publisher","first-page":"e2921","DOI":"10.1210\/clinem\/dgac174","volume":"107","author":"A Ebbehoj","year":"2022","unstructured":"Ebbehoj A, S\u00f8ndergaard E, Jepsen P et al (2022) The socioeconomic consequences of Cushing\u2019s syndrome: a nationwide cohort study. J Clin Endocrinol Metab 107:e2921\u2013e2929. https:\/\/doi.org\/10.1210\/clinem\/dgac174","journal-title":"J Clin Endocrinol Metab"},{"key":"1638_CR76","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s11102-010-0241-8","volume":"13","author":"BR Randall","year":"2010","unstructured":"Randall BR, Kraus KL, Simard MF, Couldwell WT (2010) Cost of evaluation of patients with pituitary incidentaloma. Pituitary 13:383\u2013384. https:\/\/doi.org\/10.1007\/s11102-010-0241-8","journal-title":"Pituitary"},{"key":"1638_CR77","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1055\/s-0029-1202831","volume":"117","author":"BD Arasho","year":"2009","unstructured":"Arasho BD, Schaller B, Sandu N, Zenebe G (2009) Gender-related differences in pituitary adenomas. Exp Clin Endocrinol Diabetes 117:567\u2013572. https:\/\/doi.org\/10.1055\/s-0029-1202831","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"1638_CR78","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1530\/EJE-19-0344","volume":"181","author":"DJ Lobatto","year":"2019","unstructured":"Lobatto DJ, Zamanipoor Najafabadi AH, de Vries F et al (2019) Toward value based health care in pituitary surgery: application of a comprehensive outcome set in perioperative care. Eur J Endocrinol 181:375\u2013387. https:\/\/doi.org\/10.1530\/EJE-19-0344","journal-title":"Eur J Endocrinol"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-026-01638-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-026-01638-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-026-01638-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T17:38:11Z","timestamp":1773682691000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-026-01638-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":78,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["1638"],"URL":"https:\/\/doi.org\/10.1007\/s11102-026-01638-0","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"29 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No ethical approval was necessary as the manuscript concerns a systematic review of existing literature.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"37"}}